ReviewInnovation (Cambridge (Mass.))2026

Leveraging biomarkers and primary care embedding for scalable precision cancer prevention in China: Insights from the FuSion study.

Huangbo Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.